Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2009-05-13

Clinical Trial Update: Acetato de Caspofungin (Cancidas®) in the Treatment of Fungal Infection

View source ↗

Summary

This completed clinical trial assesses caspofungin acetate (Cancidas) for treating candidiasis and aspergillosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Cancidas (caspofungin)

Snippet

Sponsor: PETHEMA Foundation | Conditions: Candidiasis, Aspergillosis | Status: COMPLETED